1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Addiction Global Clinical Trials Review, H1, 2014

Drug Addiction Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Drug Addiction Global Clinical Trials Review, H1, 2014" provides data on the Drug Addiction clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Drug Addiction. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Drug Addiction. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Drug Addiction Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Drug Addiction 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Drug Addiction to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Drug Addiction 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Drug Addiction Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Drug Addiction 33
May 27, 2014: Biotie: nepicastat study in cocaine dependence completes enrollment ahead of schedule - top-line data expected around end 2014 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
RTI International 34
Clinical Trial Overview of RTI International 34
Johnson and Johnson 35
Clinical Trial Overview of Johnson and Johnson 35
Alkermes Inc. (Inactive) 36
Clinical Trial Overview of Alkermes Inc. (Inactive) 36
SK Holdings Co., Ltd. 37
Clinical Trial Overview of SK Holdings Co., Ltd. 37
Reckitt Benckiser Group Plc 38
Clinical Trial Overview of Reckitt Benckiser Group Plc 38
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Embera NeuroTherapeutics, Inc. 40
Clinical Trial Overview of Embera NeuroTherapeutics, Inc. 40
Catalyst Pharmaceutical Partners, Inc. 41
Clinical Trial Overview of Catalyst Pharmaceutical Partners, Inc. 41
Gilead Sciences, Inc. 42
Clinical Trial Overview of Gilead Sciences, Inc. 42
DandA Pharma SAS 43
Clinical Trial Overview of DandA Pharma SAS 43
Clinical Trial Overview of Top Institutes / Government 44
National Institute on Drug Abuse 44
Clinical Trial Overview of National Institute on Drug Abuse 44
Yale University 46
Clinical Trial Overview of Yale University 46
University of Pennsylvania 47
Clinical Trial Overview of University of Pennsylvania 47
New York State Psychiatric Institute 48
Clinical Trial Overview of New York State Psychiatric Institute 48
University of California, Los Angeles 49
Clinical Trial Overview of University of California, Los Angeles 49
Johns Hopkins University 50
Clinical Trial Overview of Johns Hopkins University 50
Medical University of South Carolina 51
Clinical Trial Overview of Medical University of South Carolina 51
Baylor College of Medicine 52
Clinical Trial Overview of Baylor College of Medicine 52
University of Arkansas 53
Clinical Trial Overview of University of Arkansas 53
University of Kentucky 54
Clinical Trial Overview of University of Kentucky 54
Five Key Clinical Profiles 55
Appendix 74
Abbreviations 74
Definitions 74
Research Methodology 75
Secondary Research 75
About GlobalData 76
Contact Us 76
Disclaimer 76
Source 76

List of Tables
Drug Addiction Therapeutics, Global, Clinical Trials by Region, 2014* 7
Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Drug Addiction Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Drug Addiction Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Drug Addiction Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Drug Addiction Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Drug Addiction Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Drug Addiction Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2014* 34
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2014* 35
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Inc. (Inactive), 2014* 36
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Holdings Co., Ltd., 2014* 37
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Reckitt Benckiser Group Plc, 2014* 38
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 39
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Embera NeuroTherapeutics, Inc., 2014* 40
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalyst Pharmaceutical Partners, Inc., 2014* 41
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2014* 42
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by DandA Pharma SAS, 2014* 43
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Drug Abuse, 2014* 44
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 46
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014* 47
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by New York State Psychiatric Institute, 2014* 48
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 49
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2014* 50
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2014* 51
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2014* 52
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2014* 53
Drug Addiction Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2014* 54

List of Figures
Drug Addiction Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Drug Addiction Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Drug Addiction Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Drug Addiction Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Drug Addiction Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Drug Addiction Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Proportion of Drug Addiction to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Drug Addiction Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Drug Addiction to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Drug Addiction Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Drug Addiction Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Drug Addiction Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Drug Addiction Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Drug Addiction Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Drug Addiction Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Drug Addiction Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Drug Addiction Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Drug Addiction Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Drug Addiction Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 75

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.